Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...

A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...

Chief Executive Stephane Bancel says Moderna will work with the Trump administration. Moderna stock rose in midday trades.

Zoetis said on Friday its bird flu vaccine has received the U.S. Department of Agriculture's conditional license for use in poultry.

Moderna shares fell after the biotech company swung to a quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion, or $2.91 per share, ...

As US retail sales saw a decline of 0.9% in January, Brad Smith and Madison Mills cover the day's top developing market stories on this episode of the Morning Brief. Brown University Professor of ...

The Dow, S&P 500, and Nasdaq are little changed Friday as the stock market reacts to news of delays to President Donald Trump's reciprocal tariffs.

Moderna reported a wider loss than expected for the fourth quarter on Friday morning, and the drugmaker's sales forecast for ...

Moderna ( NASDAQ: MRNA) Q4 2024 Earnings Conference Call February 14, 2025 8:00 AM ET Lavina Talukdar - Senior Vice President, Investor Relations Stephane Bancel - Chief Executive Officer Jamey Mock - ...

Among the handful of drugmakers to advance a successful COVID-19 vaccine in 2020, Moderna—whose mRNA shot Spikevax was also ...

Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...

格隆汇2月14日｜Moderna (MRNA.US)股价因剧烈波动，触发盘中熔断。消息面上，Moderna表示，因安全顾虑，美国食品药品监督管理局 (FDA)暂停了其诺如病毒疫苗试验。莫德纳预计，FDA的暂停决定对其诺如病毒试验的影响甚微。